Callan Capital’s Nucor NUE Stock Holding History

Callan Capital’s Portfolio NUE Stock Details NUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,939	Closed	-$292K	–	366
2024 Q3	$292K	Sell	1,939 -1,027	-35%	-$155K	0.02%	269
2024 Q2	$469K	Buy	+2,966	New	+$515K	0.04%	172

Other funds holding NUE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Callan Capital's NUE Position: Q4 2024 in Review

Callan Capital sold out of Nucor (NUE) in Q4 2024, closing a stake of 1,939 shares — an estimated $292K sold.

Callan Capital first reported a position in NUE in Q2 2024 and held it in 2 quarters. The position peaked at $469K in Q2 2024. 1,178 funds tracked by Wall St. Rank hold NUE as of Q4 2024.

Callan Capital reported no remaining Nucor position as of Q4 2024 after selling out during the quarter.
Callan Capital sold 1,939 Nucor shares in Q4 2024, an estimated $292K.
Callan Capital first reported a position in Nucor in Q2 2024 and held it in 2 quarters.
Callan Capital's Nucor position peaked at $469K in Q2 2024.
1,178 funds tracked by Wall St. Rank held Nucor as of Q4 2024.

Based on Callan Capital's 13F filing for Q4 2024, filed 3 Feb 2025.